245289 Depression, drug use, and HIV among the heterosexual group in impoverished urban areas of Washington DC

Monday, October 31, 2011: 9:30 AM

Yujiang Jia, MD, DrPH , Washington DC Department of Health, HIV/AIDS, Hepatitis, STDs & TB Adminsitration, Washington DC, DC
Tiffany West-Ojo, MPH, MSPH , Washington DC Department of Health, HIV/AIDS, Hepatitis, STDs & TB Adminsitration, Washington DC, DC
Jenevieve Opoku, MPH , Washington DC Department of Health, HIV/AIDS, Hepatitis, STDs, and TB Administration, Washington DC, DC
Charles Wu, MPH , District of Columbia Department of Health, HIV/AIDS, Hepatitis, STDs, and TB Administration, Washington DC, DC
Hang Tran, MPH , Washington DC Department of Health, HIV/AIDS, Hepatitis, STDs & TB Adminsitration, Washington DC, DC
Irene Kuo, PhD, MPH , Department of Epidemiology and Biostatistics, School of Public Health and Health Services, George Washington University, Washington, DC
Gregory Phillips II, PhD , The George Washington University, School of Public Health and Health Sciences, Department of Epidemiology and Biostatistics, Washington, DC
Manya Magnus, PhD, MPH , The George Washington University, School of Public Health and Health Sciences, Department of Epidemiology and Biostatistics, Washington, DC
Alan E. Greenberg, MD, MPH , Department of Epidemiology and Biostatistics, School of Public Health and Health Services, George Washington University, Washington, DC
Nnemdi KamanuElias, MD, MPH , Washington DC Department of Health, HIV/AIDS, Hepatitis, STDs & TB Adminsitration, Washington DC, DC
Gregory Pappas, MD PhD , Senior Deputy Director, Dept. of Health, District of Columbia, Washington, DC
Objective: This study assessed the risks and prevalence for depressive symptoms among heterosexuals residing in areas of high HIV prevalence and high poverty in Washington, DC.

Methods: The first heterosexual cycle (HET-1) of the National HIV Behavioral Surveillance System in Washington, DC conducted in 2007 provided information on demographics, sexual/drug use behaviors, and HIV status. Participants were recruited using respondent driven sampling. Center for Epidemiologic Studies-Depression scale scores were used to assess depressive symptom with a cutpoint at ≥16.

Results: Of 735 participants, 58.9% were male, 4.7% HIV positive, 27.5% used non-injection drugs before/during last sex, 76.5% reported having income at <$0,000 annually, 20.0% had ever been homeless, 38.0% reported ever being physically or emotionally abused. Of the participants, 43.6% reported experiencing depressive symptoms in the past week, nearly two-thirds (63%) reported using non-injection drugs in the past year. In the multivariable logistic regression model, participants experiencing depressive symptoms in the past week were more likely to have lower income (AOR=1.7; 95%CI: 1.1-2.9, <$20,000 annually), had ever been homeless (OR=2.5; 95%CI: 1.3-3.8), had used non-injection drugs before/during last sex (AOR=1.6; 95%CI: 1.0-2.5), and had ever being physically or emotionally abused(AOR=1.8; 95%CI: 1.2-2.8).

Conclusion: Depressive symptoms were common among this sample of heterosexuals residing high HIV prevalence and high-poverty areas. The findings underscore the need for an innovative HIV prevention strategy integrating mental health and harm reduction components. Further research is needed to better understand how depressive illness might affect HIV transmission among this group.

Learning Areas:
Epidemiology
Social and behavioral sciences

Learning Objectives:
Discuss the risks and prevalence for depressive symptoms among heterosexuals residing in areas of high HIV prevalence and imporverished urban areas in Washington, DC.

Keywords: HIV/AIDS, Mental Illness

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the chief epidemiologist and lead of division of epidemiology and surveillance at HIV/AISD, Hepatitis, STDs, and TB Administration's Stratigic Bureau, Washington DC Department of Health. I have published 60 journal peer-reviewed articles. I received my medical doctoral training in China and doctor degree in public health in the United States.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

See more of: Housing, Homelessness, & HIV/AIDS
See more of: HIV/AIDS